CLINICAL_TRIALS
trial_result
· 2025-12-12
Clinical Trial Update: The Effect of Voxelotor on Cerebral Hemodynamic Response in Children With Sickle Cell Anemia [Phase 2]
Summary
Phase 2 trial evaluating voxelotor for cerebral hemodynamic response in children with sickle cell disease has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Sickle Cell Anemia in Children | Phase 2 | Status: TERMINATED